Drug Lifecycle Intelligence 360

Complete lifecycle intelligence from first submission to patent expiry, label change, safety signal, and competitor entry.

Approval history

Label velocity

Safety joins

IP runway

Request Demo See Sample Output

Problem solved

The problem this solves

Life sciences teams need decisions faster than public data can be cleaned manually. This solution compresses months of preparation into a governed, query-ready product.

VP-level and director-level teams often know which questions matter, but the required data is spread across incompatible FDA, CMS, NIH, EMA, USPTO, literature, ontology, and identity sources.

Drug Lifecycle Intelligence 360 removes the repeated engineering work by delivering the connected tables, bridge keys, and sample queries that your team would otherwise build from scratch.

What you get

Submission, approval, label, safety, patent, exclusivity, and EMA facts joined to the same drug identity.

Timeline fields for first approval, latest label change, REMS burden, market-access signal, and LOE runway.

Mechanism and target links that connect clinical and regulatory lifecycle events to biology.

Portfolio comparison-ready tables for lifecycle management and competitive intelligence.

Data graph

Data Products Powering This Solution

Each card links to a query-ready data product in the biomedical estate.

Regulatory

FDA Drug Approval & Submission Intelligence

400K+ • Monthly

Regulatory

FDA Structured Drug Label Intelligence

54K+ active labels • Weekly

Regulatory

FDA Drug Label Historical Archive

140K+ versions • Monthly

Regulatory

FDA Adverse Event Signal Intelligence (FAERS)

25M+ reports • Quarterly

Regulatory

FDA Risk Evaluation & Mitigation (REMS) Registry

400+ programs • Monthly

Clinical

EMA European Drug Authorization Intelligence

1,500+ products • Monthly

IP & Patent

FDA Orange Book Patent Intelligence

15K+ patents • Monthly

IP & Patent

FDA Orange Book Exclusivity Intelligence

8K+ exclusivity entries • Monthly

Scientific

Drug-Target Bioactivity Intelligence (ChEMBL)

2.5M compounds • Quarterly

Scientific

Protein Target Intelligence (Swiss-Prot)

20,370 human proteins • Quarterly

Financial & Market Access

Medicare Part D Drug Spending Intelligence

5K+ drugs • Annual

Sample output

Day-one query results for semaglutide

Designed sample output showing the type of redacted table your analysts can query immediately after provisioning.

Request Demo Browse Data Products

Drug Lifecycle Intelligence 360 — sample result

Signal	Value	Source
Canonical entity	semaglutide	Drug spine
Primary risk score	High confidence	Pre-computed model
Connected products	11 products	TDD catalog
Latest refresh	2026-09-01	Lineage table

Use cases

Built for the teams who own the decision

For Competitive intelligence teams

Track label expansions, safety restrictions, competitor approvals, and biosimilar activity across a class.

For Lifecycle management teams

Identify windows for indication expansion, reformulation, REMS mitigation, and LOE defense.

For Regulatory strategy teams

Compare pathway, submission, and label change histories for analog products.

FAQ

Common questions

Procurement, architecture, and analytics teams can evaluate exactly how the product will land in your environment.

Query on day one

Sample SQL included

Does Lifecycle 360 include both FDA and EMA context?

Yes. EMA authorized products are bridged to FDA drug identities where exact matching is possible.

Can we monitor label change velocity?

Yes. Historical SPL records are versioned so warning, indication, and adverse-reaction changes can be tracked over time.

How quickly is the product available?

A governed BigQuery or Snowflake delivery can be provisioned in less than 24 hours after access approval.

See This Solution In Action

We'll walk through live warehouse queries and sample outputs for your specific use case.

Request Demo